505 Stock Overview
An investment holding company, provides healthcare services in Singapore. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
AsiaMedic Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$0.011 |
| 52 Week High | S$0.013 |
| 52 Week Low | S$0.009 |
| Beta | 1 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -8.33% |
| 3 Year Change | -26.67% |
| 5 Year Change | -15.38% |
| Change since IPO | -97.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| 505 | SG Healthcare | SG Market | |
|---|---|---|---|
| 7D | 0% | 0.7% | 0.3% |
| 1Y | -8.3% | -9.4% | 15.3% |
Return vs Industry: 505 exceeded the SG Healthcare industry which returned -9.4% over the past year.
Return vs Market: 505 underperformed the SG Market which returned 15.3% over the past year.
Price Volatility
| 505 volatility | |
|---|---|
| 505 Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 5.2% |
| Market Average Movement | 4.2% |
| 10% most volatile stocks in SG Market | 12.6% |
| 10% least volatile stocks in SG Market | 1.9% |
Stable Share Price: 505's share price has been volatile over the past 3 months compared to the SG market.
Volatility Over Time: Insufficient data to determine 505's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1974 | n/a | Arifin Kosumo Kwek Zhi Bin | www.asiamedic.com.sg |
AsiaMedic Limited, an investment holding company, provides healthcare services in Singapore. The company offers diagnostic imaging, radiology, health screening, and medical wellness services. It also provides medical aesthetic products and related services.
AsiaMedic Limited Fundamentals Summary
| 505 fundamental statistics | |
|---|---|
| Market cap | S$12.70m |
| Earnings (TTM) | S$1.19m |
| Revenue (TTM) | S$26.19m |
10.7x
P/E Ratio0.5x
P/S RatioIs 505 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 505 income statement (TTM) | |
|---|---|
| Revenue | S$26.19m |
| Cost of Revenue | S$21.21m |
| Gross Profit | S$4.97m |
| Other Expenses | S$3.79m |
| Earnings | S$1.19m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.001 |
| Gross Margin | 18.99% |
| Net Profit Margin | 4.53% |
| Debt/Equity Ratio | 3.7% |
How did 505 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/06 03:34 |
| End of Day Share Price | 2025/02/05 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
AsiaMedic Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.